Assignment history

Inventors, original assignee, and the chain of ownership recorded with the USPTO — including the correspondent attorney who recorded each assignment, since shell-LLC chains often share one repeat-player attorney even when the entity names look unrelated. Surfaces NPE / patent-troll patterns: shell-entity transfers, known asserters in the chain, repeat correspondent fingerprints, pre-litigation assignments, and bankruptcy fire-sales.

Assignment history

Inventors

Gary Ashley Stafford (Abbott Diabetes Care Inc.)

Original assignee

Abbott Diabetes Care Inc. is the original assignee. Abbott Diabetes Care Inc. ships products embodying the claims, specifically continuous glucose monitoring systems. Their primary line of business is the development, manufacturing, and marketing of glucose monitoring systems and other medical devices. Abbott Diabetes Care Inc. is currently operating as a subsidiary of Abbott Laboratories.

Assignment timeline

The USPTO Assignment Center has no recorded post-issuance assignments for US patent 8613703.

Timeline diagram

timeline
    title Ownership of US 8613703
    2008 : Filed by Abbott Diabetes Care Inc
    2013 : Issued to Abbott Diabetes Care Inc
    2026 : Currently held by Abbott Diabetes Care Inc

NPE / troll-pattern signals

Shell-entity transfer — not present
Known asserter in the chain — not present
Repeat correspondent across the chain — not present
Cascading transfers — not present
Pre-litigation transfer — not present
Bankruptcy fire-sale — not present
Privateering — not present
Defensive aggregator (anti-NPE) — not present

Verdict

Insufficient data
There are no recorded assignments for US patent 8613703 in the USPTO Assignment Center, beyond the original assignment to Abbott Diabetes Care Inc. at the time of filing. Therefore, there is insufficient data to determine any NPE or patent-troll patterns.

Verification: https://assignmentcenter.uspto.gov/ (search for patent number 8613703).